- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01389089
Effective Treatment of Posttraumatic and Postoperative Edema
October 3, 2023 updated by: Reto Babst, Luzerner Kantonsspital
Effective Treatment of Posttraumatic and Postoperative Edema in Patients With Ankle- and Hindfoot Fractures. A Randomized Controlled Trial Comparing Multi-layer Compression Therapy and A-V Impulse Compression to the Standard Treatment With Ice
Edema control after ankle- and hindfoot fractures is important.
Multi-layer compression bandages or A-V Impulse compression may are more effective in reducing edema than ice.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
After ankle- and hindfoot fractures, edema has a major impact on the time point of surgical intervention and may increases the risk of wound complications and infection postoperatively.
Effective treatment of edema, therefore, is of great importance.
The aim of this study was to evaluate the efficacy of the multi-layer compression therapy and of the A-V Impulse compression (AVI) in reducing ankle- and hindfoot edema as compared to the standard treatment with ice.
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Luzern, Switzerland, 6000 16
- Luzerner Kantonsspital, Unfallchirurgie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria:
- Age 18-65 years
- Inpatients
- Acute ankle- or hindfoot fractures (malleolar-, calcaneus-, talus-, and pilon- tibial fractures) including fractures temporary stabilized with an external fixator)
- No walking aids before trauma
- Written informed consent
- Monotrauma
- Preoperative and/or postoperative edema
Preoperative inclusion
- if delay of surgery due to ankle edema
- if fracture stable enough for temporary removal of orthesis
Exclusion criteria:
- Diabetes Mellitus
- Lymphedema
- Peripheral arterial occlusive disease (PAD)
- Decompensated heart failure or renal insufficiency
- Acute bacterial infection
- Severe osteoporosis
- Pathological fractures
- Known tumors
- Postthrombotic syndrome
- Thrombosis
- Open fractures
- Polytrauma, cerebral trauma
- Neurological deficiencies
- Diuretics
- Pregnancy
- Alcohol or drug abuse
- Psychological disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multi-layer compression bandage
A multi-layer compression bandage was applied to the lower limb and foot of the patient to reduce edema.
Additionally, the limb was constantly elevated.
|
Application of a multi-layer compression bandage to the foot and lower limb (two layers of wool followed by several layers of a short stretch bandage).
Other Names:
|
|
Sham Comparator: Control group
The Control group received ice gel packs and elevation to reduce edema.
|
ice gel pack combined with elevation
|
|
Active Comparator: A-V Impulse compression
An A-V Impulse compression device was used to reduce edema.
|
A-V Impulse compression dosage: 130mmHg exerted to the sole of the foot for one second, every twenty second.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ankle edema as measured with the figure-of-eight20 method
Time Frame: Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Follow-up at 6 weeks postoperative.
|
The figure-of-eight20 is a validated method to measure ankle edema with a simple spring tape.
The spring tape follows a figure of eight around the ankle joint.
|
Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Follow-up at 6 weeks postoperative.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain scores measured on the Visual Analogue Scale (VAS)
Time Frame: Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Follow-ups at 6 weeks, 12 weeks and 1 year postoperative.
|
Visual Analogue Scales were used to assess a daily pain score reflecting strongest and average pain perceived during the previous 24 hours, night pain and pain frequency.
|
Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Follow-ups at 6 weeks, 12 weeks and 1 year postoperative.
|
|
Patient satisfaction with treatment scores measured on the Visual Analogue Scale
Time Frame: Participants were assessed for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative --> assessment at the day of discharge.
|
Visual Analogue Scales were used to assess patient satisfaction with the assigned treatment.
The patients had to record their satisfaction with the treatment before surgery and after surgery.
|
Participants were assessed for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative --> assessment at the day of discharge.
|
|
Number of days until possible operation
Time Frame: Participants were assessed daily for the duration of preoperative hospital stay, an expected average of 5 days.
|
The surgeon daily had to assess whether the patient was ready for operation or not.
The wrinkling test served as a criteria for decision making.
Accordingly the number of days until possible operation was recorded.
|
Participants were assessed daily for the duration of preoperative hospital stay, an expected average of 5 days.
|
|
Number of postoperative hospitalization days
Time Frame: Participants were assessed daily for the duration of postoperative hospital stay, an expected average of 5 days.
|
Postoperatively the physiotherapist each day had to record whether or not the patient was ready for discharge.
Discharge criteria: 1. patient is able to walk 20 meters and one flight of stairs with crutches.
2. the wound is dry and not irritated.
Accordingly, the number of days of postoperative hospitalization until discharge criteria were reached was recorded.
|
Participants were assessed daily for the duration of postoperative hospital stay, an expected average of 5 days.
|
|
Range of motion of the ankle joint and foot.
Time Frame: Participants were assessed daily for the duration of postoperative hospital stay, an expected average of 5 days. Follow-up at 6 weeks postoperative.
|
Plantar flexion, dorsal flexion, inversion and eversion were assessed with a hydrogoniometer.
|
Participants were assessed daily for the duration of postoperative hospital stay, an expected average of 5 days. Follow-up at 6 weeks postoperative.
|
|
Amount of daily intake of medication
Time Frame: Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative.
|
The intake of daily pain medication was recorded for the instay period (Dafalgan, Novalgin, opiates).
Furthermore, the patient file was screened for any Nonsteroidal anti-inflammatory drugs (not allowed).
|
Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative.
|
|
Number of adverse events as a measure of safety in each group
Time Frame: Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Patient file was screened for adverse events until 1 year postoperatively.
|
Adverse events were defined as: bacterial infection, implant breakage, secondary dislocations, massive wound complications, thrombosis, embolism. |
Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Patient file was screened for adverse events until 1 year postoperatively.
|
|
Lower limb function (Foot and ankle ability measure)
Time Frame: 12 weeks postoperative, 1 year postoperative.
|
Questionnaire, self-assessed by the patient.
To assess function and participation.
|
12 weeks postoperative, 1 year postoperative.
|
|
General Health (SF-36)
Time Frame: 12 weeks postoperative,1 year postoperative.
|
Generic assessment of the health status with the SF-36.
|
12 weeks postoperative,1 year postoperative.
|
|
Patient satisfaction scores on overall outcome measured on the Visual Analogue Scale
Time Frame: 12 weeks and 1 year postoperative.
|
Patients had to record on the VAS on how satisfied they were with the overall outcome.
|
12 weeks and 1 year postoperative.
|
|
Amount of volumetric lower limb edema
Time Frame: Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Follow-up at 6 weeks postoperative.
|
Measurements of circumference of the lower limb were used to calculate lower limb volume.
The circumferences of the lower limb were measured in increments of 4 cm from ankle level until below the knee joint.
|
Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative. Follow-up at 6 weeks postoperative.
|
|
Number of complains of discomfort or intolerances considering the intervention
Time Frame: Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative.
|
Every day the patients were asked by the physiotherapist if they had any sort of complains considering the assigned treatment (discomfort or intolerances).
|
Participants were assessed daily for the duration of hospital stay, an expected average of 5 days preoperative and 5 days postoperative.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Reto Babst, Prof.Dr.med., Luzerner Kantonsspital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
January 1, 2009
Study Completion (Actual)
January 1, 2010
Study Registration Dates
First Submitted
June 23, 2011
First Submitted That Met QC Criteria
July 6, 2011
First Posted (Estimated)
July 7, 2011
Study Record Updates
Last Update Posted (Actual)
October 5, 2023
Last Update Submitted That Met QC Criteria
October 3, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 616
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edema
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
Hoffmann-La RocheCompletedDiabetic Macular Edema | Uveitic Macular EdemaUnited States
-
Alexandria UniversityRecruitingDiabetic Macular Edema | Center-involved Diabetic Macular EdemaEgypt
-
Curacle Co., Ltd.Not yet recruitingDiabetic Macular Edema | Diabetic Macular Edema (DME) | DME
-
OcugenRecruitingDiabetic Macular Edema | Center Involved Diabetic Macular EdemaUnited States
-
Eye-yon MedicalCompletedChronic Cornel EdemaNetherlands, Israel, Germany, Spain
-
EyePoint Pharmaceuticals, Inc.RecruitingDiabetic Macular Edema | Diabetic Macular Edema (DME) | DMEIsrael, United States, Poland, Germany, Slovakia
-
EyePoint Pharmaceuticals, Inc.RecruitingDiabetic Macular Edema | Diabetic Macular Edema (DME) | DMEUnited States, Hungary, Czechia, Brazil, Germany
Clinical Trials on Multi-layer compression bandage
-
DeRoyal Industries, Inc.Royal College of Surgeons, Ireland; Enterprise Ireland; Tyndall National InstituteCompletedVenous Leg Ulcer | Venous Insufficiency of LegIreland
-
MiMedx Group, Inc.Completed
-
Hospital Clinic of BarcelonaCompleted
-
University of AlcalaCompleted
-
Hvidovre University HospitalCompletedTotal Knee ArthroplastyDenmark
-
Instituto Nacional de Cancer, BrazilCompletedBreast Neoplasms | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema | Lymphedema, SecondaryBrazil
-
Massachusetts General HospitalNational Cancer Institute (NCI)TerminatedBreast Cancer | LymphedemaUnited States
-
Laboratoires URGOUnknown
-
TheraclionCompletedVaricose Ulcer | Veins Diseases | Vein, VaricoseAustria
-
Gerencia de Atención Primaria, MadridFondo de Investigacion Sanitaria; Instituto de Salud Carlos IIICompleted